Health care has had a tough year. Where we stand on our 5 stocks in the sector

[ad_1] There’s Eli Lilly (LLY), and then there’s everybody else. That’s a simple way to describe the performance of the Club’s health-care holdings so far this year, in what’s been…

Want an annual investment return of up to 12%? This ‘boring’ strategy’s the way to go, investor says

[ad_1] Everyone wants to make a quick buck, but the idiosyncrasies of economic cycles and market conditions often make that a difficult task. There’s a lot of noise, but one…